XML 141 R112.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting - Schedule of segment financial information adjusted (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Segment Reporting Information [Line Items]                      
Total revenues $ 54,424 $ 47,490 $ 46,922 $ 45,743 $ 48,391 $ 46,186 $ 45,689 $ 44,520 $ 194,579 $ 184,786 $ 177,546
Cost of products sold                 156,447 153,448 146,533
Benefit costs                 6,594 2,810 2,179
Operating expenses                   18,990 18,448
Operating income (loss) $ 824 2,574 (1,373) 1,996 3,114 2,504 2,121 1,799 4,021 9,538 10,386
Operating Segments                      
Segment Reporting Information [Line Items]                      
Total revenues                 134,128    
Operating Segments | Pharmacy Services                      
Segment Reporting Information [Line Items]                      
Total revenues                 134,128 130,601 119,965
Cost of products sold                   121,799 111,949
Benefit costs                   2,810 2,179
Operating expenses                   1,335 1,267
Operating income (loss)                 4,699 4,657 4,570
Operating Segments | Retail/LTC                      
Segment Reporting Information [Line Items]                      
Total revenues                 83,989 79,398 81,100
Cost of products sold                   56,066 57,339
Benefit costs                   0 0
Operating expenses                   16,774 16,324
Operating income (loss)                 620 6,558 7,437
Operating Segments | Corporate/Other                      
Segment Reporting Information [Line Items]                      
Total revenues                 606 16 18
Cost of products sold                   0 0
Benefit costs                   0 0
Operating expenses                   952 918
Operating income (loss)                 (805) (936) (900)
Intersegment Eliminations                      
Segment Reporting Information [Line Items]                      
Total revenues                 (29,693) (25,229) (23,537)
Cost of products sold                   (24,417) (22,755)
Benefit costs                   0 0
Operating expenses                   (71) (61)
Operating income (loss)                 $ (769) (741) (721)
As Previously Reported                      
Segment Reporting Information [Line Items]                      
Total revenues                   184,765 177,526
Cost of products sold                   153,410 146,490
Benefit costs                   2,810 2,179
Operating expenses                   19,028 18,491
Operating income (loss)                   9,517 10,366
As Previously Reported | Operating Segments | Pharmacy Services                      
Segment Reporting Information [Line Items]                      
Total revenues                   130,596 119,963
Cost of products sold                   121,746 111,883
Benefit costs                   2,810 2,179
Operating expenses                   1,285 1,225
Operating income (loss)                   4,755 4,676
As Previously Reported | Operating Segments | Retail/LTC                      
Segment Reporting Information [Line Items]                      
Total revenues                   79,398 81,100
Cost of products sold                   56,081 57,362
Benefit costs                   0 0
Operating expenses                   16,848 16,436
Operating income (loss)                   6,469 7,302
As Previously Reported | Operating Segments | Corporate/Other                      
Segment Reporting Information [Line Items]                      
Total revenues                   0 0
Cost of products sold                   0 0
Benefit costs                   0 0
Operating expenses                   966 891
Operating income (loss)                   (966) (891)
As Previously Reported | Intersegment Eliminations                      
Segment Reporting Information [Line Items]                      
Total revenues                   (25,229) (23,537)
Cost of products sold                   (24,417) (22,755)
Benefit costs                   0 0
Operating expenses                   (71) (61)
Operating income (loss)                   (741) (721)
Adjustments                      
Segment Reporting Information [Line Items]                      
Total revenues   $ 221 $ 214 $ 50 $ 6 $ 5 $ 4 $ 6   21 20
Cost of products sold                   38 43
Benefit costs                   0 0
Operating expenses                   (38) (43)
Operating income (loss)                   21 20
Adjustments | Operating Segments | Pharmacy Services                      
Segment Reporting Information [Line Items]                      
Total revenues                   5 2
Cost of products sold                   53 66
Benefit costs                   0 0
Operating expenses                   50 42
Operating income (loss)                   (98) (106)
Adjustments | Operating Segments | Retail/LTC                      
Segment Reporting Information [Line Items]                      
Total revenues                   0 0
Cost of products sold                   (15) (23)
Benefit costs                   0 0
Operating expenses                   (74) (112)
Operating income (loss)                   89 135
Adjustments | Operating Segments | Corporate/Other                      
Segment Reporting Information [Line Items]                      
Total revenues                   16 18
Cost of products sold                   0 0
Benefit costs                   0 0
Operating expenses                   (14) 27
Operating income (loss)                   30 (9)
Adjustments | Intersegment Eliminations                      
Segment Reporting Information [Line Items]                      
Total revenues                   0 0
Cost of products sold                   0 0
Benefit costs                   0 0
Operating expenses                   0 0
Operating income (loss)                   $ 0 $ 0